{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:01:36Z","timestamp":1790107296912,"version":"4.0.1"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.humpath.2026.106035","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T16:43:28Z","timestamp":1767804208000},"page":"106035","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["RNA in situ hybridization based TRIM63 characterization in tubulocystic renal cell carcinoma"],"prefix":"10.1016","volume":"176","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0874-8964","authenticated-orcid":false,"given":"Ankur R.","family":"Sangoi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Mehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara R.","family":"Harik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2026.106035_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2025.105862","article-title":"Diagnostic accuracy of TRIM63 RNA-ISH in MiTF-rearranged renal cell carcinomas: results from a 331-tumor validation cohort","volume":"161","author":"Lee","year":"2025","journal-title":"Hum Pathol"},{"issue":"8","key":"10.1016\/j.humpath.2026.106035_bib2","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/s41379-021-00803-z","article-title":"TRIM63 is a sensitive and specific biomarker for MiT family aberration-associated renal cell carcinoma","volume":"34","author":"Wang","year":"2021","journal-title":"Mod Pathol"},{"issue":"11","key":"10.1016\/j.humpath.2026.106035_bib3","doi-asserted-by":"crossref","first-page":"6438","DOI":"10.21037\/tcr-24-60","article-title":"Management of translocation carcinomas of the kidney","volume":"13","author":"Ged","year":"2024","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.humpath.2026.106035_bib4","doi-asserted-by":"crossref","DOI":"10.1007\/s00428-025-04250-y","article-title":"Perivascular epithelioid cell tumors of the urinary bladder: a multi-institutional clinicopathologic and molecular analysis of 21 cases","author":"Sangoi","year":"2025","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2026.106035_bib5","doi-asserted-by":"crossref","DOI":"10.1097\/PAS.0000000000002411","article-title":"Renal epithelioid angiomyolipoma: prognostic implications of targeted immunohistochemical and molecular markers in conjunction with clinicopathologic features","author":"Sangoi","year":"2025","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.humpath.2026.106035_bib6","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s12032-024-02305-9","article-title":"Evaluation of TRIM63 RNA in situ hybridization (RNA-ISH) as a potential biomarker for alveolar soft-part sarcoma (ASPS)","volume":"41","author":"Taylor","year":"2024","journal-title":"Med Oncol"},{"issue":"3","key":"10.1016\/j.humpath.2026.106035_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2024.103049","article-title":"TRIM63 RNA in situ hybridization (RNA-ISH) assay: Biomarker characterization in a tertiary clinical practice","volume":"105","author":"Humble","year":"2025","journal-title":"Lab Invest"},{"key":"10.1016\/j.humpath.2026.106035_bib8","doi-asserted-by":"crossref","DOI":"10.1097\/PAS.0000000000002457","article-title":"Tubulocystic renal cell carcinoma with pure morphology and confirmed \"Wild Type\" FH\/2SC immunophenotype: clinicopathologic series of 30 patients","author":"Harik","year":"2025","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.humpath.2026.106035_bib9","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/PAS.0000000000002411","article-title":"Renal epithelioid angiomyolipoma: prognostic implications of targeted immunohistochemical and molecular markers in conjunction with clinicopathologic features","volume":"49","author":"Sangoi","year":"2025","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.humpath.2026.106035_bib10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/PAP.0000000000000443","article-title":"Cystic features in renal epithelial neoplasms and their increasing clinical and pathologic significance","volume":"31","author":"Tretiakova","year":"2024","journal-title":"Adv Anat Pathol"},{"issue":"11","key":"10.1016\/j.humpath.2026.106035_bib11","article-title":"Clinicopathologic study of 28 cases of tubulocystic renal cell carcinoma: is it time to reclassify it as a tubulocystic renal cell tumor?","volume":"16","author":"Xiao","year":"2024","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.humpath.2026.106035_bib12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/PAP.0000000000000332","article-title":"Chameleon TFE3-translocation RCC and how gene partners can change morphology: accurate diagnosis using contemporary modalities","volume":"29","author":"Tretiakova","year":"2022","journal-title":"Adv Anat Pathol"},{"issue":"6","key":"10.1016\/j.humpath.2026.106035_bib13","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/ajcp\/aqad089","article-title":"Lessons from 801 clinical TFE3\/TFEB fluorescence in situ hybridization assays performed on renal cell carcinoma suspicious for MiTF family aberrations","volume":"160","author":"Wang","year":"2023","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1016\/j.humpath.2026.106035_bib14","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41379-018-0185-5","article-title":"Tubulocystic renal cell carcinoma: a distinct clinicopathologic entity with a characteristic genomic profile","volume":"32","author":"Sarungbam","year":"2019","journal-title":"Mod Pathol"},{"issue":"11","key":"10.1016\/j.humpath.2026.106035_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2025.100873","article-title":"TRIM63 overexpression in FISH-negative MiTF family altered renal cell carcinoma (MiTF RCC)","volume":"38","author":"Mannan","year":"2025","journal-title":"Mod Pathol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726000043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726000043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T08:38:58Z","timestamp":1788770338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817726000043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":15,"alternative-id":["S0046817726000043"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106035","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RNA in situ hybridization based TRIM63 characterization in tubulocystic renal cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106035"}}